P. VanderLaan

D. Costa, C. Kelly, P. VanderLaan, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Repeatedly Nondiagnostic Thyroid Fine-Needle Aspirations Do Not Modify Malignancy Risk

E. Marqusee, J. Krane, P. VanderLaan, 2011, Acta Cytologica.

Molecular Testing Turnaround Time in Non-Small-Cell Lung Cancer: Monitoring a Moving Target.

D. Costa, D. Rangachari, P. VanderLaan, 2018, Clinical lung cancer.

Rapidly fatal advanced EGFR-mutated lung cancers and the need for rapid tumor genotyping in clinical practice.

D. Costa, E. Folch, D. Rangachari, 2016, Cancer treatment communications.

Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non–small-cell Lung Cancer

D. Costa, G. Weiss, R. Gill, 2020, Clinical Lung Cancer.

Natural killer T cells in lipoprotein metabolism and atherosclerosis

G. Getz, C. Reardon, P. VanderLaan, 2011, Thrombosis and Haemostasis.

The Frequency of ‘Atypia of Undetermined Significance’ Interpretations for Thyroid Fine-Needle Aspirations Is Negatively Correlated with Histologically Proven Malignant Outcomes

J. Krane, E. Cibas, P. VanderLaan, 2011, Acta Cytologica.

Atypia of undetermined significance and nondiagnostic rates in The Bethesda System for Reporting Thyroid Cytopathology are inversely related.

A. Renshaw, J. Krane, P. VanderLaan, 2012, American journal of clinical pathology.

Usefulness of diagnostic qualifiers for thyroid fine-needle aspirations with atypia of undetermined significance.

E. Marqusee, J. Krane, P. VanderLaan, 2011, American journal of clinical pathology.

Non–small cell lung cancer predictive biomarker testing via immunocytochemistry: Ways of future past?

P. VanderLaan, 2019, Cancer cytopathology.

The rapidly evolving landscape of biomarker testing in non–small cell lung cancer

D. Costa, D. Rangachari, P. VanderLaan, 2020, Cancer cytopathology.

Safety and Efficacy of PD‐1 Inhibitors Among HIV‐Positive Patients With Non–Small Cell Lung Cancer

D. Costa, F. Marty, M. Cheng, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Radiologic and autopsy findings in a case of fatal immune checkpoint inhibitor-associated pneumonitis.

D. Costa, D. Rangachari, P. VanderLaan, 2018, Cancer treatment and research communications.

CD1d Selectively Down Regulates the Expression of the Oxidized Phospholipid-Specific E06 IgM Natural Antibody in Ldlr−/− Mice

G. Getz, J. Witztum, C. Binder, 2020, Antibodies.

Pulmonary amyloidosis as the presenting finding in a patient with multiple myeloma

P. VanderLaan, R. Kronen, D. Ziehr, 2022, Respiratory medicine case reports.

Impact of a Modified HistoGel Method for Processing Endocervical Curettage Specimens on Diagnostic Yield.

J. Hecht, P. VanderLaan, Yigu Chen, 2020, American journal of clinical pathology.

The unusual suspects: an overview of the minor leukocyte populations in atherosclerosis

C. Reardon, P. VanderLaan, 2005 .

Patient‐facing communication for cytopathologists: A framework for disclosing diagnostic error

P. VanderLaan, Yael K. Heher, C. K. Harris, 2022, Cancer cytopathology.

Invariant Natural Killer T-Cells and Total CD1d Restricted Cells Differentially Influence Lipid Metabolism and Atherosclerosis in Low Density Receptor Deficient Mice

G. Getz, Chyung-Ru Wang, C. Reardon, 2019, International journal of molecular sciences.

False positive diagnosis of lymph node metastases in a 34‐year‐old woman with a history of extraskeletal myxoid chondroscarcoma: A root cause analysis

P. VanderLaan, Yael K. Heher, Yigu Chen, 2019, Cancer cytopathology.

A 50-year-old man with cirrhosis and progressive hypoxemia.

Kristin E. Burke, J. McSparron, M. Curry, 2014, Annals of the American Thoracic Society.

Activity of Brigatinib in the Setting of Alectinib Resistance Mediated by ALK I1171S in ALK-Rearranged Lung Cancer.

S. Kobayashi, D. Costa, D. Rangachari, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Mammary analogue secretory carcinoma: Update on a new diagnosis of salivary gland malignancy

D. Deschler, E. Kozin, A. Remenschneider, 2014, The Laryngoscope.

The immune system and murine atherosclerosis.

G. Getz, C. Reardon, P. VanderLaan, 2007, Current drug targets.

Adequacy of Lymph Node Transbronchial Needle Aspirates Using Convex Probe Endobronchial Ultrasound for Multiple Tumor Genotyping Techniques in Non–Small-Cell Lung Cancer

A. Majid, O. Kocher, D. Costa, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The impact of pathology grossing protocol measures to improve pathologic nodal staging in lung cancer.

A. Bankier, P. VanderLaan, G. Bozovic, 2021, Cancer treatment and research communications.

De novo ERBB2 amplification causing intrinsic resistance to erlotinib in EGFR-L858R mutated TKI-naïve lung adenocarcinoma.

D. Costa, Siraj M. Ali, K. Gowen, 2017, Lung cancer.

COVID‐19 pandemic impact on cytopathology practice in the post‐lockdown period: An international, multicenter study

F. Fulciniti, G. Alí, G. Fontanini, 2022, Cancer cytopathology.

Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies Guideline from the College of American Pathologists (CAP): implications for the cytology community.

P. VanderLaan, 2020, Journal of the American Society of Cytopathology.

Atypical histologic presentation of Pneumocystis pneumonia as granulomatous lung nodules

S. Riedel, P. VanderLaan, C. Alonso, 2021 .

RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer

G. Getz, K. Ross, S. Ramaswamy, 2015, Nature Communications.

Molecular Diagnostics in Cytopathology

S. Roy-Chowdhuri, P. VanderLaan, J. Stewart, 2019, Springer International Publishing.

Molecular Diagnostics in Lung Cytology

P. VanderLaan, 2018, Molecular Diagnostics in Cytopathology.

Updates in Lung Cancer Cytopathology.

P. VanderLaan, 2018, Surgical pathology clinics.

Mutations in TP53, PIK3CA, PTEN and other genes in EGFR mutated lung cancers: Correlation with clinical outcomes.

S. Kobayashi, D. Costa, H. Reddi, 2017, Lung cancer.

De novo ALK kinase domain mutations are uncommon in kinase inhibitor-naïve ALK rearranged lung cancers.

D. Dias-Santagata, A. Majid, S. Kobayashi, 2016, Lung cancer.

Responses to the multitargeted MET/ALK/ROS1 inhibitor crizotinib and co-occurring mutations in lung adenocarcinomas with MET amplification or MET exon 14 skipping mutation.

S. Kobayashi, D. Costa, S. Schulman, 2015, Lung cancer.

Fine‐needle aspiration and core needle biopsy: An update on 2 common minimally invasive tissue sampling modalities

P. VanderLaan, 2016, Cancer cytopathology.

Lung Cancer with a High Tumor Mutational Burden.

D. Costa, P. VanderLaan, Deepa Rangachari, 2018, The New England journal of medicine.

Molecular markers: Implications for cytopathology and specimen collection

P. VanderLaan, 2015, Cancer cytopathology.

PD-L1 testing using the clone 22C3 pharmDx kit for selection of patients with non-small cell lung cancer to receive immune checkpoint inhibitor therapy: are cytology cell blocks a viable option?

D. Costa, P. VanderLaan, Vanda F Torous, 2018, Journal of the American Society of Cytopathology.

Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3–PD‐L1 ≥50% Expression in Lung Adenocarcinoma

S. Kobayashi, D. Costa, X. Le, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

CCAAT/Enhancer Binding Protein β Is Dispensable for Development of Lung Adenocarcinoma

Kwok-Kin Wong, S. Kobayashi, D. Costa, 2015, PloS one.

Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma

L. Chirieac, W. Richards, D. Sugarbaker, 2019, Cancer.

Utilization of ancillary studies in the cytologic diagnosis of respiratory lesions: The papanicolaou society of cytopathology consensus recommendations for respiratory cytology

K. Geisinger, N. Lindeman, O. Lin, 2016, Diagnostic cytopathology.

Endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA): An overview and update for the cytopathologist

A. Majid, E. Folch, P. VanderLaan, 2014, Cancer cytopathology.

Smoking status and self-reported race affect the frequency of clinically relevant oncogenic alterations in non-small-cell lung cancers at a United States-based academic medical practice.

A. Majid, O. Kocher, D. Costa, 2013, Lung cancer.

Detection of Crizotinib-Sensitive Lung Adenocarcinomas With MET, ALK, and ROS1 Genomic Alterations via Comprehensive Genomic Profiling.

S. Kobayashi, V. Miller, D. Costa, 2015, Clinical lung cancer.

Lung cancer diagnosis and staging in the minimally invasive age with increasing demands for tissue analysis.

D. Costa, E. Folch, P. VanderLaan, 2015, Translational lung cancer research.

Experience with targeted next generation sequencing for the care of lung cancer: insights into promises and limitations of genomic oncology in day-to-day practice.

A. Majid, D. Costa, X. Le, 2015, Cancer treatment communications.

6-Phosphogluconate dehydrogenase regulates tumor cell migration in vitro by regulating receptor tyrosine kinase c-Met.

V. Sukhatme, P. VanderLaan, B. Chan, 2013, Biochemical and biophysical research communications.

Yield of biliary stent cytology: Is it time to think lean?

T. Berzin, D. Pleskow, M. Alagappan, 2019, Endoscopy International Open.

Success and failure rates of tumor genotyping techniques in routine pathological samples with non-small-cell lung cancer.

A. Majid, O. Kocher, D. Costa, 2014, Lung cancer.

Small cell transformation of non-small cell lung cancer on immune checkpoint inhibitors: uncommon or under-recognized?

D. Costa, P. VanderLaan, A. Varkaris, 2020, Journal for immunotherapy of cancer.

Results from the 2019 American Society of Cytopathology survey on rapid onsite evaluation (ROSE)-part 2: subjective views among the cytopathology community.

Christopher C. Griffith, P. Illei, J. Reynolds, 2020, Journal of the American Society of Cytopathology.

Pill aspiration presenting as an endobronchial tumor.

A. Majid, E. Folch, P. VanderLaan, 2014, Journal of bronchology & interventional pulmonology.

The Clinical Use of Genomic Profiling to Distinguish Intrapulmonary Metastases From Synchronous Primaries in Non-Small-Cell Lung Cancer: A Mini-Review.

S. Ou, V. Miller, D. Costa, 2015, Clinical lung cancer.

Global impact of the COVID‐19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries

F. Fulciniti, G. Fontanini, L. Bubendorf, 2020, Cancer cytopathology.

Combined molecular and histologic end points inform cancer risk estimates for thyroid nodules classified as atypia of undetermined significance

Allison M. Onken, J. Hennessey, P. VanderLaan, 2021, Cancer cytopathology.

Site Specificity of Atherosclerosis: Site-Selective Responses to Atherosclerotic Modulators

G. Getz, C. Reardon, P. VanderLaan, 2004, Arteriosclerosis, thrombosis, and vascular biology.

Cases of ALK-Rearranged Lung Cancer with 5-Year Progression-Free Survival with Crizotinib as Initial Precision Therapy.

S. Kobayashi, D. Costa, X. Le, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Osseous and chondromatous metaplasia in calcific aortic valve stenosis.

R. Mitchell, M. Torre, R. Padera, 2016, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Vascular remodeling of the small pulmonary arteries and measures of vascular pruning on computed tomography

G. Washko, A. Bankier, M. Mittleman, 2021, Pulmonary circulation.

Cytologic rapid on-site evaluation of transthoracic computed tomography-guided lung needle biopsies: who should perform ROSE? A cross-institutional analysis of procedural and diagnostic outcomes.

R. Sheiman, P. VanderLaan, Helen H Wang, 2015, Journal of the American Society of Cytopathology.

A Case Report on Papillary Muscle Rupture Following Mitral Valve Replacement in the Setting of Previously Undiagnosed Amyloidosis.

P. VanderLaan, L. Chu, O. Chaudhary, 2021, A&A practice.

Pulmonary Sclerosing Pneumocytoma.

Y. Gesthalter, P. VanderLaan, M. Parikh, 2018, Journal of bronchology & interventional pulmonology.

Brief Report: EGFR-mutated lung cancers resistant to osimertinib through EGFR-C797S respond to 1st generation reversible EGFR inhibitors but eventually acquire EGFR-T790M/C797S in preclinical models and clinical samples.

C. Paweletz, P. Jänne, S. Kobayashi, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Complete pathologic response to short-course neoadjuvant alectinib in mediastinal node positive (N2) ALK rearranged lung cancer.

J. Aronovitz, Page Widick, D. Costa, 2022, Lung cancer.

A CASE OF FULMINANT CARDIAC SARCOIDOSIS RESEMBLING GIANT CELL MYOCARDITIS

P. Zimetbaum, P. VanderLaan, A. Garan, 2020 .

The Growth Rate of Subsolid Lung Adenocarcinoma Nodules at Chest CT.

Allison M. Onken, A. Bankier, L. Ngo, 2020, Radiology.

Growth Assessment of Pulmonary Adenocarcinomas Manifesting as Subsolid Nodules on CT: Comparison of Diameter-Based and Volume Measurements.

Allison M. Onken, A. Bankier, R. Gill, 2019, Academic radiology.

A microthymoma and no germinal centre in myasthenia gravis.

D. Sugarbaker, C. Mcnamee, P. VanderLaan, 2013, European Journal of Cardio-Thoracic Surgery.

Role of imaging in predicting tumor spread through airspaces (STAS): what are the next steps

A. Bankier, P. VanderLaan, B. Heidinger, 2020, Journal of thoracic disease.

EGFR Testing in Advanced Non-Small-Cell Lung Cancer, A Mini-Review.

D. Costa, Y. Sheikine, E. Folch, 2016, Clinical lung cancer.

Pre‐analytic error: A significant patient safety risk

P. VanderLaan, Yael K. Heher, Yigu Chen, 2018, Cancer cytopathology.

Tumor biomarker testing in non-small-cell lung cancer: A decade of change.

Adnan Majid, A. Majid, S. Kobayashi, 2018, Lung cancer.

Molecular Testing Turnaround Time for Non-Small Cell Lung Cancer in Routine Clinical Practice Confirms Feasibility of CAP/IASLC/AMP Guideline Recommendations: A Single-center Analysis.

D. Costa, P. VanderLaan, Yael K. Heher, 2017, Clinical lung cancer.

De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitors.

A. Majid, D. Costa, X. Le, 2015, Lung cancer.

EGFR exon 19 insertion EGFR-K745_E746insIPVAIK and others with rare XPVAIK amino-acid insertions: Preclinical and clinical characterization of the favorable therapeutic window to all classes of approved EGFR kinase inhibitors.

S. Kobayashi, D. Costa, Susumu S. Kobayashi, 2023, Lung cancer.

Current and future trends in non–small cell lung cancer biomarker testing: The American experience

S. Roy-Chowdhuri, P. VanderLaan, 2020, Cancer cytopathology.

Mechanisms of acquired resistance to MET tyrosine kinase inhibitors (TKIs) in MET exon 14 (METex14) mutant non-small cell lung cancer (NSCLC).

C. Paweletz, A. Redig, P. Jänne, 2018 .

Visceral Pleural Invasion in Pulmonary Adenocarcinoma: Differences in CT Patterns between Solid and Subsolid Cancers.

A. Bankier, M. Mayerhoefer, P. VanderLaan, 2019, Radiology. Cardiothoracic imaging.

"Rounding" the Size of Pulmonary Nodules: Impact of Rounding Methods on Nodule Management, as Defined by the 2017 Fleischner Society Guidelines.

A. Bankier, D. Costa, U. Nemec, 2017, Academic radiology.

Lung Adenocarcinoma Manifesting as Pure Ground‐Glass Nodules: Correlating CT Size, Volume, Density, and Roundness with Histopathologic Invasion and Size

A. Bankier, D. Costa, U. Nemec, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Size Measurement and T-staging of Lung Adenocarcinomas Manifesting as Solid Nodules ≤30 mm on CT: Radiology-Pathology Correlation.

Sidhu P. Gangadharan, Alexander A. Bankier, A. Bankier, 2017, Academic radiology.

Risk stratification of cytologically indeterminate thyroid nodules with nondiagnostic or benign cytology on repeat FNA: Implications for molecular testing and surveillance

P. VanderLaan, P. Hartzband, Michiya Nishino, 2023, Cancer cytopathology.

Thymic carcinoma with brain metastases: A rare presentation of a rare malignancy

D. Costa, Elizabeth M. Gaughan, P. VanderLaan, 2016 .

Recovery of giant-cell myocarditis using combined cytolytic immunosuppression and mechanical circulatory support.

R. Kociol, P. VanderLaan, E. Gelfand, 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Thermoablative Techniques for Excessive Central Airway Collapse

A. Majid, F. Kheir, S. Gangadharan, 2020, Journal of bronchology & interventional pulmonology.

Bronchoscopic Thermoablative Techniques to Stabilize Excessive Central Airway Collapse: An Ex Vivo Pilot Study on Sheep Tracheal Tissue

A. Majid, F. Kheir, S. Gangadharan, 2019, A35. INTERVENTIONAL PULMONOLOGY.

Argon Plasma Coagulation (APC) for the Treatment of Excessive Dynamic Airway Collapse (EDAC)

A. Chee, A. Majid, F. Kheir, 2021, Journal of bronchology & interventional pulmonology.

The natural course of incidentally detected, small, subsolid lung nodules-is follow-up needed beyond current guideline recommendations?

A. Bankier, Mario Silva, P. VanderLaan, 2019, Translational lung cancer research.

An Unusual Cause of Functional Mitral Stenosis

Jamie Diamond, P. VanderLaan, L. Chu, 2021, JACC. Case reports.

Histopathological Demonstration of Subacute Endothelialization Following Aneurysm Retreatment with the Pipeline Embolization Device.

C. Ogilvy, A. Alturki, A. Thomas, 2018, World Neurosurgery.

EGFR -mutated lung cancers resistant to osimertinib through EGFR -C797S respond to 1 st generation reversible EGFR inhibitors but eventually acquire EGFR -T790M/C797S in preclinical models and clinical samples

C. Paweletz, P. Jänne, S. Kobayashi, 2019 .

Diagnostic Accuracy of Endobronchial Optical Coherence Tomography for the Microscopic Diagnosis of Usual Interstitial Pneumonia.

H. Ott, Amita Sharma, M. Mino‐Kenudson, 2021, American journal of respiratory and critical care medicine.

Comparison of plasma-thrombin, HistoGel, and CellGel cell block preparation methods with paired ThinPrep slides in the setting of mediastinal granulomatous disease.

P. VanderLaan, Vanda F Torous, Yigu Chen, 2019, Journal of the American Society of Cytopathology.

EGFR exon 20 insertion mutations and ERBB2 mutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates

D. Costa, Susumu S. Kobayashi, P. VanderLaan, 2023, Translational lung cancer research.

The 2023 Bethesda System for Reporting Thyroid Cytopathology.

F. Schmitt, P. Vielh, Syed Z. Ali, 2023, Thyroid : official journal of the American Thyroid Association.

Bronchial Rheoplasty Reduces Goblet Cell Hyperplasia and Airway Inflammation in Patients With Chronic Bronchitis

A. Ing, P. VanderLaan, S. Fernández-Bussy, 2023, C21. "CUTTING" EDGE: CLINICAL STUDIES IN INTERVENTIONAL PULMONARY AND PLEURAL DISEASE.

Lymphangioleiomyomatosis.

P. VanderLaan, A. Sclafani, 2018, The New England journal of medicine.

Reply to Kalverda et al.: Endobronchial Optical Coherence Tomography: Shining New Light on Diagnosing Usual Interstitial Pneumonitis?

H. Ott, M. Mino‐Kenudson, J. Wain, 2022, American journal of respiratory and critical care medicine.

Brief overview of the updated third edition of the Bethesda System for Reporting Thyroid Cytopathology

Syed Z. Ali, P. VanderLaan, 2023, Diagnostic Histopathology.

Characterization of the natural killer T-cell response in an adoptive transfer model of atherosclerosis.

G. Getz, L. Blachowicz, Chyung-Ru Wang, 2007, The American journal of pathology.

The 2023 Bethesda System for reporting thyroid cytopathology.

P. Vielh, Syed Z. Ali, P. VanderLaan, 2023, Journal of the American Society of Cytopathology.

Measuring and assuring quality performance in cytology: A toolkit

P. VanderLaan, Yael K. Heher, Yigu Chen, 2017, Cancer cytopathology.

The unusual suspects: an overview of the minor leukocyte populations in atherosclerosis

C. Reardon, P. VanderLaan, 2005 .

Usefulness of diagnostic qualifiers for thyroid fine-needle aspirations with atypia of undetermined significance.

E. Marqusee, J. Krane, P. VanderLaan, 2011, American journal of clinical pathology.

Review of the Pathologic Characteristics in Myhre Syndrome: Gain-of-Function Pathogenic Variants in SMAD4 cause a Multisystem Fibroproliferative Response

A. Majid, C. Strange, M. Lindsay, 2022, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

EGFR-A763_Y764insFQEA: A unique exon 20 insertion mutation that displays sensitivity to all classes of approved lung cancer EGFR tyrosine kinase inhibitors.

D. Costa, Susumu S. Kobayashi, P. VanderLaan, 2019, Journal of Clinical Oncology.

Rapid examination of lung tissues by nonlinear microscopy.

P. VanderLaan, Yue Sun, Timothy D Weber, 2024, American journal of clinical pathology.